OUR TEAM
Dr. Carola Schipke
Interim-CEO / CSO
More than 10 years experience in biomarker development in the field of neurodegenerative diseases, also in clinical settings, fundamental research and method development for biomarker-based diagnostic approaches in neurology and psychiatry. Author on more than 30 peer-reviewed publications, more than 15 as first or last author.